Avandra

About Avandra

Avandra Imaging empowers pharmaceutical companies, medical device manufacturers, and researchers by providing comprehensive data solutions for clinical trials, health outcomes, and patient care, aiming to transform healthcare research with advanced imaging data solutions.

Products & Services

Clinical Trial and R&D:Accelerates clinical trials and development with comprehensive data analysis and management solutions.

Precision Medicine and HEOR:Supports informed decisions with real-world evidence and advanced analytics for commercialization.

Healthcare AI:Offers extensive real-world data sets to train algorithms and conduct research.

Specialties

Clinical Trials Precision Medicine Health Economics and Outcomes Research (HEOR) Healthcare AI Imaging Data Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Unknown T: - FT: Unknown	A: 17750000 MR: - FA: $17.75M FAN: 17750000	D: 2025-02-18 FD: 2025-02-18	8 investors

Unknown Latest

2025-02-18

$17.8M

8 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

R

Ryan Tarzy

CEO/Founder

S

Scott Katz

Head of Sales

S

Scott Ponder

VP Business Development

J

Jeanne Manalo, Ph.D.

Head of Scientific Innovation

A

Angela Liu

Head of Operations

D

Dave Shah

Founding Engineer / Head of Engineering

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Avandra Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised